✦ LIBER ✦

12-month efficacy and safety of OROS®MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH

✍ Scribed by Peter Hoare; H. Remschmidt; R. Medori; C. Ettrich; A. Rothenberger; P. Santosh; M. Schmit; Q. Spender; R. Tamhne; M. Thompson; C. Tinline; G. E. Trott

Publisher: Springer
Year: 2005
Tongue: English
Weight: 213 KB
Volume: 14
Category: Article
ISSN: 1018-8827
DOI: 10.1007/s00787-005-0486-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Symptom control in children and adolesce

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS®MPH

✍ H. Remschmidt; P. Hoare; C. Ettrich; A. Rothenberger; P. Santosh; M. Schmidt; Q. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 275 KB

Efficacy of Strattera in Children and Ad

Efficacy of Strattera in Children and Adolescents with Attention Deficit Hyperactivity Disorder

✍ I. N. Vakula; Yu. Sh. Vasyanina; Z. Kh. Gorbunova; E. Yu. Nikiforova; E. I. Pono 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 143 KB

Efficacy and safety of atomoxetine for a

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—meta-analysis and meta-regression analysis

✍ Jackie Y. W. Cheng; Ronald Y. L. Chen; John S. N. Ko; Emil M. L. Ng 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 244 KB